Page last updated: 2024-08-24

mifobate and rosiglitazone

mifobate has been researched along with rosiglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Desvergne, B; Escher, P; Michalik, L; Niesor, E; Rieusset, J; Touri, F; Wahli, W	1

Other Studies

1 other study(ies) available for mifobate and rosiglitazone

Article	Year
A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Molecular endocrinology (Baltimore, Md.), 2002, Volume: 16, Issue:11 Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Aged; Animals; Anti-Obesity Agents; Cell Differentiation; Epididymis; HeLa Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Molecular Structure; Organophosphorus Compounds; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors	2002

Article

Year

A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.

Molecular endocrinology (Baltimore, Md.), 2002, Volume: 16, Issue:11

Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Aged; Animals; Anti-Obesity Agents; Cell Differentiation; Epididymis; HeLa Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Molecular Structure; Organophosphorus Compounds; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors

2002